PharmAthene (PIP)

Add to Watchlists
Create an Alert
1.84 +0.12  +6.98% AMEX Dec 19, 8:00PM BATS Real time Currency in USD

PharmAthene Research and Development Expense (Quarterly):

1.729M for Sept. 30, 2014

View 4,000+ financial data types

View Full Chart

PharmAthene Research and Development Expense (Quarterly) Chart

Export Data
Save Image

PharmAthene Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 2005. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 30, 2014 1.729M
June 30, 2014 2.373M
March 31, 2014 3.427M
Dec. 31, 2013 4.098M
Sept. 30, 2013 2.556M
June 30, 2013 3.402M
March 31, 2013 5.234M
Dec. 31, 2012 4.747M
Sept. 30, 2012 5.139M
June 30, 2012 4.919M
March 31, 2012 4.705M
Dec. 31, 2011 4.531M
Sept. 30, 2011 4.884M
June 30, 2011 5.984M
March 31, 2011 5.820M
Dec. 31, 2010 3.811M
Sept. 30, 2010 6.172M
   
June 30, 2010 5.940M
March 31, 2010 4.952M
Dec. 31, 2009 6.291M
Sept. 30, 2009 7.884M
June 30, 2009 10.23M
March 31, 2009 5.695M
Dec. 31, 2008 5.337M
Sept. 30, 2008 9.414M
June 30, 2008 11.18M
March 31, 2008 5.877M
Dec. 31, 2007 5.825M
Sept. 30, 2007 3.647M
June 30, 2007
March 31, 2007 3.092M
Dec. 31, 2006 2.423M
Sept. 30, 2006 1.670M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for
Advertisement

PIP Research and Development Expense (Quarterly) Benchmarks

Companies
Siga Technologies 2.742M
Opexa Therapeutics 3.174M
Northwest Biotherapeutics 22.71M

PIP Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 1.729M Sep 2014
Maximum 6.291M Dec 2009
Average 4.536M

PIP Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("PIP", "r_and_d_expense")
  • Last 5 data points: =YCS("PIP", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.